Search
European Drug Report 2024: Trends and Developments
The European Drug Report 2024: Trends and Developments presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report provides a comprehensive set of...
SAMHSA Trauma responsive care
Provides an overview and guidance for how to provide trauma-responsive care to women and men with substance use disorders.
Self-Care Toolbox For UNC Horizons Team 2020 version
This document provides self-care tools for the professional caring for women in treatment.
An easy-to-implement guide to standardize online information to support potential patients in finding treatment
Provides an easy-to-implement guide to standardize online information to support potential patients in finding treatment.
A comprehensive assessment was created for women. It is used after a woman screens positive for a substance problem.
A comprehensive assessment was created for women. It is used after a woman screens positive for a substance problem.
Screens for problems with drugs like cannabis, opioids, stimulants.
Screens for problems with drugs like cannabis, opioids, stimulants. It does not screen for alcohol use problems.
A screener for drug problems during pregnancy
A screener for drug problems during pregnancy. It also provides prompts to respond to the screening results.
Day 2, 11:00 - 12.30, ISSUP, Official Launch of the Global Women’s Network for Treatment and Recovery
Presented at Thessaloniki 2024 - Panel: Official Launch of the Global Women´s Network for Treatment and Recovery, on the 27th of June, 2024.
Self-Care Toolbox for women in recovery
This document provides self-care tools for women who are seeking or in recovery.
Trauma exposure across the lifespan among individuals engaged in treatment with medication for opioid use disorder: differences by gender, PTSD status, and chronic pain
Background
There is little research on lifetime trauma exposure among individuals undergoing medication treatment for opioid use disorder (MOUD). A multisite study examined the prevalence of lifetime trauma and explored differences based...
Trauma exposure across the lifespan among individuals engaged in treatment with medication for opioid use disorder: differences by gender, PTSD status, and chronic pain
Background: Limited research has been conducted on lifetime trauma exposure among individuals undergoing medication treatment for opioid use disorder (MOUD). A multisite study provided an opportunity to investigate the prevalence of...
People who use drugs engagement in substance use disorder services and harm reduction: evaluation, challenges and future direction of a community-based intervention
Background:
Since 1996, an urban community-based organization has been providing screening, testing, overdose prevention, referrals, and access to treatment for substance use disorders (SUD) and communicable diseases such as HIV through...
Trauma exposure across the lifespan among individuals engaged in treatment with medication for opioid use disorder: differences by gender, PTSD status, and chronic pain
There is little study of lifetime trauma exposure among individuals engaged in medication treatment for opioid use disorder (MOUD). A multisite study provided the opportunity to examine the prevalence of lifetime trauma and differences by gender, PTSD status, and chronic pain.
Join the Power of Collaboration! Sumate al Poder de la Colaboración!
In partnership with ISSUP, we come together to generate global data about the most cross-cutting aspects of the treatment and recovery of women with SUD
